Novel Anti-Inflammatory Effects of Brimonidine on Propionibacterium acnes-Induced Inflammatory Reaction

참고문헌 (9)

1. Katz LJ, "Brimonidine tartrate 0.2% twice daily vs timolol 0.5%twice daily: 1-year results in glaucoma patients. Brimonidine Study Group", Am J Ophthalmol, 127, pp.20~26 (1999)
2. Fowler J, "Once-daily topical brimonidine tartrate gel 0•5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies", Br J Dermatol, 166, pp.633~641 (2012)
3. Steinhoff M, "Facial erythema of rosacea- aetiology, different pathophysiologies and treatment options", Acta Derm Venereol, 96, pp.579~586 (2016)
4. Jackson JM, "The role of brimonidine tartrate gel in the treatment of rosacea", Clin Cosmet Investig Dermatol, 8, pp.529~538 (2015)
5. Liu PF, "Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris", Curr Drug Metab, 16, pp.245~254 (2015)
6. Piwnica D, "Vasoconstriction and anti-inflammatory properties of the selective α-adrenergic receptor agonist brimonidine", J Dermatol Sci, 75, pp.49~54 (2014)
7. Hsia E, "Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors", Exp Dermatol, 27, pp.763~768 (2018)
8. Dong CJ, "Presynaptic inhibition by α2 receptor", adenylate cyclase, J Neurosci, pp.2014, 34[DOI]
9. Gerlo S, "Cyclic AMP : a selective modulator of NF-κB action", Cell Mol Life Sci, 68, pp.3823~3841 (2011)

관련 논문AI추천